ZA953418B - Combination preparations with an amount of a p-oxybenzoic acid derivative and an HMG-CoA reductase inhibitor - Google Patents

Combination preparations with an amount of a p-oxybenzoic acid derivative and an HMG-CoA reductase inhibitor

Info

Publication number
ZA953418B
ZA953418B ZA953418A ZA953418A ZA953418B ZA 953418 B ZA953418 B ZA 953418B ZA 953418 A ZA953418 A ZA 953418A ZA 953418 A ZA953418 A ZA 953418A ZA 953418 B ZA953418 B ZA 953418B
Authority
ZA
South Africa
Prior art keywords
hmg
amount
acid derivative
coa reductase
reductase inhibitor
Prior art date
Application number
ZA953418A
Other languages
English (en)
Inventor
Matthias Heil
Michael Schliack
Klaus Seibel
Original Assignee
Klinge Co Chem Pharm Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Klinge Co Chem Pharm Fab filed Critical Klinge Co Chem Pharm Fab
Publication of ZA953418B publication Critical patent/ZA953418B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA953418A 1994-04-26 1995-04-26 Combination preparations with an amount of a p-oxybenzoic acid derivative and an HMG-CoA reductase inhibitor ZA953418B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4414537A DE4414537A1 (de) 1994-04-26 1994-04-26 Kombinationspräparate mit einem Gehalt an einem p-Oxybenzoesäurederivat und einem HMG-CoA-Reduktase-Hemmer

Publications (1)

Publication Number Publication Date
ZA953418B true ZA953418B (en) 1996-01-11

Family

ID=6516472

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA953418A ZA953418B (en) 1994-04-26 1995-04-26 Combination preparations with an amount of a p-oxybenzoic acid derivative and an HMG-CoA reductase inhibitor

Country Status (5)

Country Link
AU (1) AU2407895A (xx)
DE (1) DE4414537A1 (xx)
EE (1) EE9400258A (xx)
WO (1) WO1995028924A1 (xx)
ZA (1) ZA953418B (xx)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3326164A1 (de) * 1983-07-20 1985-01-31 Klinge Pharma GmbH, 8000 München Neue p-oxibenzoesaeure-derivate, sowie verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
CA2003478A1 (en) * 1988-12-12 1990-06-12 Leonard G. Dennick Combination of an hmg coa reductase inhibitor and other type of serum cholesterol reducing agent and method for lowering serum cholesterol using such combination
CA2048395A1 (en) * 1990-08-23 1992-02-24 Henry Y. Pan Method for preventing onset of or treating type iii hyperlipoproteinemia employing pravastatin
DE4032037A1 (de) * 1990-10-09 1992-04-16 Klinge Co Chem Pharm Fab Neue p-oxibenzoesaeurederivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
US5202029A (en) * 1991-03-13 1993-04-13 Caron Kabushiki Kaisha Process for purification of hmg-coa reductase inhibitors

Also Published As

Publication number Publication date
AU2407895A (en) 1995-11-16
WO1995028924A1 (de) 1995-11-02
EE9400258A (et) 1996-02-15
DE4414537A1 (de) 1995-11-02

Similar Documents

Publication Publication Date Title
AU1022795A (en) Method for preventing or reducing risk of onset of cardiovascular events employing an HMG CoA reductase inhibitor
HK1022105A1 (en) Naringin and naringenin as 3-hydroxy-3-methylglutaryl coa(hmg-coa) reductase inhibitor
AU8140898A (en) Inhibitors of beta-lactamases and uses therefor
HUP9900666A3 (en) Phosphodiesterase inhibitor phenanthridines derivatives and use thereof
AU662997B2 (en) Condensed heterocyclic derivative and weedkiller
AP9801401A0 (en) Combination of an aldose reductase inhibitor and a glycogen phosphorlylase inhibitor
AU2453295A (en) Combination of a cholesterol absorption inhibitor and a cholesterol synthesis inhibitor
GB9200114D0 (en) Dual inhibitors of no synthase and cyclooxygenase
AU4617696A (en) Transformer and method of assembly
AU7204694A (en) Fastening device for furniture construction and method of manufacture
AU6672598A (en) Dual threaded fastener for metal components and method
AU1273297A (en) Flame inhibitor composition and use thereof
AU2058992A (en) HMG-COA reductase inhibitors
AU2907697A (en) Decontamination of metal
AU2523897A (en) A circulator and components thereof
GB2227662B (en) Lowering serum cholesterol using a hmg coa reductase inhibitor and a squaline synthetase inhibitor
HUP0002103A3 (en) Hmg-coa reductase inhibitor preparation process
IL114439A0 (en) Iminoxycarboxylates and derivatives as inhibitors of leukotriene biosynthesis
EP0461548A3 (en) Method for preventing a second heart attack employing and hmg coa reductase inhibitor
ZA948337B (en) Pyrrolidine derivatives inhibitors of leukotriene biosynthesis
ZA953418B (en) Combination preparations with an amount of a p-oxybenzoic acid derivative and an HMG-CoA reductase inhibitor
AU637321B2 (en) Quinoline and pyridine anchors for a hmg-coa reductase inhibitors
AU5659796A (en) 2-hydroxyphenylalkylamine derivatives and maillard reaction inhibitors
AU5014496A (en) Diphenylmethyl-azetidinone compounds and elastase inhibitor
GB9303051D0 (en) 17b-nmonosubstituted carbamoyl-11-oxo-4-aza-5-a-androst-en-3-one testosterone-5-alpha reductase inhibitors